KELONIA THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR KLN-1010, AN IN VIVO BCMA CAR-T THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

Reuters · 4d ago

Please log in to view news